Molecular and Physiological Characterization of Thyroid Hormone Transporter
Molecular and Physiological Characterization of Thyroid Hormone Transporter
批准号:
10670111
负责人:
ABE Takaaki
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have isolated a novel liver-specific organic anion transporter, LST-1, that is expressed exclusively in the human, rat and mouse liver. LST-1 is a new gene family located between the organic anion transporter family and prostaglandin transporter. LST-1 transport taurocholate (Km ; 13.6 μM) in a sodium-independent manner. LST-1 also shows broad substrate specificity. It transports conjugated steroids (dehydroepiandrosterone sulfate, estradiol-17β-glucuronide and estrone-3-sulfate), eicosanoids (prostaglandin EィイD22ィエD2, thromboxane BィイD22ィエD2, leukotriene CィイD24ィエD2, leukotriene EィイD24ィエD2), and thyroid hormones, reflecting hepatic multispecificity. LST-1 is probably the most important transporter in the human liver for clearance of bile acids and organic anions since hepatic levels of another organic anion transporter, OATP is very low. We have also isolated rat counter part, rlst-1. Rlst-1 is excusively expressed in the liver and in both the bile duct ligation model and the cecum ligation and puncture model, the mRNA expression levels of rlst-1 were down-regulate, suggesting rlst-1 may be under feedback regulation of cholestasis by biliary obstruction and/or sepsis.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kakyo M.et al.: "Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transport thyroid hormones and taurocholate"FEBS Lett.. 445. 343-346 (1999)
Kakyo M.等人:“运输甲状腺激素和牛磺胆酸盐的新型有机阴离子转运蛋白亚型 (oatp3) 的分子特征和组织分布”FEBS Lett.. 445. 343-346 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tokui T. et al.: "Pravastatin,an HMG-CoA reductase inhibitor,is transported by rat liver organic anion transporting polypeptide,oatp2." Phamaceutical Res.(in press).
Tokui T. 等人:“普伐他汀是一种 HMG-CoA 还原酶抑制剂,由大鼠肝脏有机阴离子转运多肽 oatp2 转运。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kakyo M. et al.: "Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transport thyroid hormones and taurochorate"Gastroenterology. 117. 770-775 (1999)
Kakyo M. 等人:“运输甲状腺激素和牛磺胆酸盐的新型有机阴离子转运蛋白亚型 (oatp3) 的分子特征和组织分布”胃肠病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kakyo M., Sakagami H., Nishio T., Nakai D., Nakagomi R., Tokui T., Naitoh T., Matsuno S., Kondo H., Abe T., and Yawo H.: "Immunohistochemical distribution and functional characterization of an organic anion transporting polypeptide2 (oatp2)"FEBS Lett.. 44
Kakyo M.、Sakagami H.、Nishio T.、Nakai D.、Nakagomi R.、Tokui T.、Naitoh T.、Matsuno S.、Kondo H.、Abe T. 和 Yawo H.:“免疫组织化学分布和功能
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Abe T.et al.: "Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transport thyroid hormones and taurocholate"J. Biol. Chem.. 273. 22395-22401 (1998)
Abe T.等人:“运输甲状腺激素和牛磺胆酸盐的新型有机阴离子转运蛋白亚型 (oatp3) 的分子特征和组织分布”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Drug discovery for Diabetic Nephropathy through altering gut microbiota community
-
批准号:20K20604
-
项目类别:Grant-in-Aid for Challenging Research (Pioneering)
-
资助金额:$16.64万
-
财政年份:2020
-
负责人:ABE Takaaki
-
依托单位:
Development of novel drugs for CKD
-
批准号:26293031
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.9万
-
财政年份:2014
-
负责人:ABE Takaaki
-
依托单位:
Relation between 1-metyl adenosinea and rheumatoid arthritis
-
批准号:26305007
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.4万
-
财政年份:2014
-
负责人:ABE Takaaki
-
依托单位:
Indole analog mitochonic acid-5 (MA-5) has novel therapeutic effects on kidney injury
-
批准号:26670070
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2014
-
负责人:ABE Takaaki
-
依托单位:
Biomarkers for ischemia and renal faiure
-
批准号:24659062
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:ABE Takaaki
-
依托单位:
Blockade of renal malignant cycle by transcriptional regulation of SLCO transporter
-
批准号:23390033
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2011
-
负责人:ABE Takaaki
-
依托单位:
Development of in vivo evaluation system of human organic anion transpoter
-
批准号:20390043
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.56万
-
财政年份:2008
-
负责人:ABE Takaaki
-
依托单位:
Clinical application of the origanic anion transporter family
-
批准号:18390045
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.82万
-
财政年份:2006
-
负责人:ABE Takaaki
-
依托单位:
Functional regulation and clinical application of the organic anion transporter LST family.
-
批准号:16390038
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.54万
-
财政年份:2004
-
负责人:ABE Takaaki
-
依托单位:
Molecular characterization of the organic anion transporter family
-
批准号:14370777
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.77万
-
财政年份:2002
-
负责人:ABE Takaaki
-
依托单位:
Identification of organic anion transporter LST-2 which expressed in the gastrointestinal cancers: clinical implication for anticancer drug delivery.
-
批准号:13557218
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.49万
-
财政年份:2001
-
负责人:ABE Takaaki
-
依托单位:
Genetic introduction of thyroid hormone transporter in Bood-Brain-Barrier
-
批准号:11557188
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.64万
-
财政年份:1999
-
负责人:ABE Takaaki
-
依托单位:
海外基金